Skip to content

Clinical trials

Phase 1 Hemorrhage trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemorrhage Phase: Phase 1 Country / region: United States Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20071
20102
20111
20133
20142
20151
20161
20172
20181
20191
20222
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Withdrawn3
Recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Zynex Monitoring Solutions2
Biomedica Management Corporation1
Cayuga Biotech, Inc.1
Cellphire Therapeutics, Inc.1
Corewell Health East1
Daiichi Sankyo1
Entegrion, Inc.1
George Washington University1
HemCon Medical Technologies, Inc1
Hutchmed1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemorrhage22
Hemostatic Disorders3
Cerebral Hemorrhage2
Hematologic Diseases2
Thrombocytopenia2
Thrombosis2
Abdominal Pain1
Anemia, Aplastic1
Autoimmune Diseases1
Blood Coagulation Disorders1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.